Differential uptake of isomeric 2-bromohydroquinone-glutathione conjugates into kidney slices

Serrine Lau, Mary G. McMenamin, Terrence Monks

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

2-Bromo-(diglutathion-Syl)hydroquinone (2-Br-[diGSyl]HQ) is a more potent nephrotoxicant than any of three mono-substituted isomers. The reason for this differential toxicity is unknown. We now report that the rate of uptake of 2-Br-(diGSyl)HQ, 2-Br-3-(GSyl)HQ, 2-Br-5-(GSyl)-HQ and 2-Br-6(GSyl)HQ by kidney slices was 2.4, 1.2, 1.0 and 0.3 nmoles/mg/10 min, respectively. AT-125 (0.5 mM) inhibited γ-glutamyl transpeptidase (GGT) in intact and homogenized kidney slices by 47% and 92%, respectively and decreased the accumulation of the isomeric [35S]-conjugates by 49%, 21%, 25% and 30%, respectively. The data suggest that the accumulation of 2-Br-(GSyl)HQ conjugates into isolated kidney slices may in part be mediated by GGT and that the more extensive renal uptake of the di-substituted conjugate may be partially responsible for its enhanced nephrotoxicity. In addition, 2-Br-(diGSyl)HQ gave rise to the most covalently bound material of the different isomers studied suggesting that both physiological and biochemical factors contribute to the potent and selective nephrotoxicity of this compound.

Original languageEnglish (US)
Pages (from-to)223-230
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume152
Issue number1
DOIs
StatePublished - Apr 15 1988
Externally publishedYes

Fingerprint

Glutathione
acivicin
Kidney
Isomers
gamma-Glutamyltransferase
Toxicity
2-bromohydroquinone
2-bromo-(diglutathion-S-yl)hydroquinone
2-bromo-3-(glutathion-S-yl)hydroquinone
2-bromo-6-(glutathion-S-yl)hydroquinone
hydroquinone

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Differential uptake of isomeric 2-bromohydroquinone-glutathione conjugates into kidney slices. / Lau, Serrine; McMenamin, Mary G.; Monks, Terrence.

In: Biochemical and Biophysical Research Communications, Vol. 152, No. 1, 15.04.1988, p. 223-230.

Research output: Contribution to journalArticle

@article{4af46df1ff764f9ebaa2096b028abc24,
title = "Differential uptake of isomeric 2-bromohydroquinone-glutathione conjugates into kidney slices",
abstract = "2-Bromo-(diglutathion-Syl)hydroquinone (2-Br-[diGSyl]HQ) is a more potent nephrotoxicant than any of three mono-substituted isomers. The reason for this differential toxicity is unknown. We now report that the rate of uptake of 2-Br-(diGSyl)HQ, 2-Br-3-(GSyl)HQ, 2-Br-5-(GSyl)-HQ and 2-Br-6(GSyl)HQ by kidney slices was 2.4, 1.2, 1.0 and 0.3 nmoles/mg/10 min, respectively. AT-125 (0.5 mM) inhibited γ-glutamyl transpeptidase (GGT) in intact and homogenized kidney slices by 47{\%} and 92{\%}, respectively and decreased the accumulation of the isomeric [35S]-conjugates by 49{\%}, 21{\%}, 25{\%} and 30{\%}, respectively. The data suggest that the accumulation of 2-Br-(GSyl)HQ conjugates into isolated kidney slices may in part be mediated by GGT and that the more extensive renal uptake of the di-substituted conjugate may be partially responsible for its enhanced nephrotoxicity. In addition, 2-Br-(diGSyl)HQ gave rise to the most covalently bound material of the different isomers studied suggesting that both physiological and biochemical factors contribute to the potent and selective nephrotoxicity of this compound.",
author = "Serrine Lau and McMenamin, {Mary G.} and Terrence Monks",
year = "1988",
month = "4",
day = "15",
doi = "10.1016/S0006-291X(88)80703-4",
language = "English (US)",
volume = "152",
pages = "223--230",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Differential uptake of isomeric 2-bromohydroquinone-glutathione conjugates into kidney slices

AU - Lau, Serrine

AU - McMenamin, Mary G.

AU - Monks, Terrence

PY - 1988/4/15

Y1 - 1988/4/15

N2 - 2-Bromo-(diglutathion-Syl)hydroquinone (2-Br-[diGSyl]HQ) is a more potent nephrotoxicant than any of three mono-substituted isomers. The reason for this differential toxicity is unknown. We now report that the rate of uptake of 2-Br-(diGSyl)HQ, 2-Br-3-(GSyl)HQ, 2-Br-5-(GSyl)-HQ and 2-Br-6(GSyl)HQ by kidney slices was 2.4, 1.2, 1.0 and 0.3 nmoles/mg/10 min, respectively. AT-125 (0.5 mM) inhibited γ-glutamyl transpeptidase (GGT) in intact and homogenized kidney slices by 47% and 92%, respectively and decreased the accumulation of the isomeric [35S]-conjugates by 49%, 21%, 25% and 30%, respectively. The data suggest that the accumulation of 2-Br-(GSyl)HQ conjugates into isolated kidney slices may in part be mediated by GGT and that the more extensive renal uptake of the di-substituted conjugate may be partially responsible for its enhanced nephrotoxicity. In addition, 2-Br-(diGSyl)HQ gave rise to the most covalently bound material of the different isomers studied suggesting that both physiological and biochemical factors contribute to the potent and selective nephrotoxicity of this compound.

AB - 2-Bromo-(diglutathion-Syl)hydroquinone (2-Br-[diGSyl]HQ) is a more potent nephrotoxicant than any of three mono-substituted isomers. The reason for this differential toxicity is unknown. We now report that the rate of uptake of 2-Br-(diGSyl)HQ, 2-Br-3-(GSyl)HQ, 2-Br-5-(GSyl)-HQ and 2-Br-6(GSyl)HQ by kidney slices was 2.4, 1.2, 1.0 and 0.3 nmoles/mg/10 min, respectively. AT-125 (0.5 mM) inhibited γ-glutamyl transpeptidase (GGT) in intact and homogenized kidney slices by 47% and 92%, respectively and decreased the accumulation of the isomeric [35S]-conjugates by 49%, 21%, 25% and 30%, respectively. The data suggest that the accumulation of 2-Br-(GSyl)HQ conjugates into isolated kidney slices may in part be mediated by GGT and that the more extensive renal uptake of the di-substituted conjugate may be partially responsible for its enhanced nephrotoxicity. In addition, 2-Br-(diGSyl)HQ gave rise to the most covalently bound material of the different isomers studied suggesting that both physiological and biochemical factors contribute to the potent and selective nephrotoxicity of this compound.

UR - http://www.scopus.com/inward/record.url?scp=0023912849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023912849&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(88)80703-4

DO - 10.1016/S0006-291X(88)80703-4

M3 - Article

VL - 152

SP - 223

EP - 230

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -